Evidence map›Paper›PMID 33232587›Full record

ReviewESC heart failure2021

Insights into heart failure hospitalizations, management, and services during and beyond COVID-19.

Sarah J Charman, Lazar Velicki, Nduka C Okwose, Amy Harwood, Gordon McGregor, Arsen Ristic, Prithwish Banerjee, Petar M Seferovic, Guy A MacGowan, Djordje G Jakovljevic

Registry-linked trialAbstract readReview
In one paragraph

Review in ESC heart failure, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05416879 (Lifestyle Behaviours of Women Newly Diagnosed With Heart Failure), which is not on this map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05416879 recruitingnot on this mapstarted 2022, after this paper: background citation

Lifestyle Behaviours of Women Newly Diagnosed With Heart Failure: A Quantitative and Qualitative Approach

TypeobservationalSponsorNewcastle UniversityRan2022 to 2026Enrolled40ConditionsHeart FailureArmsActigraph GT3X+BT
3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sarah J CharmanCardiovascular Research Division, Translational and Biosciences Research Institutes, Newcastle University, Newcastle upon Tyne, UK.ORCID 0000-0002-3029-7672
Lazar VelickiFaculty of Medicine, University of Novi Sad, Novi Sad, Serbia.
Nduka C OkwoseCardiovascular Research Division, Translational and Biosciences Research Institutes, Newcastle University, Newcastle upon Tyne, UK.
Amy HarwoodFaculty of Health and Life Sciences, Coventry University, Coventry, UK.
Gordon McGregorFaculty of Health and Life Sciences, Coventry University, Coventry, UK.
Arsen RisticFaculty of Medicine, University of Belgrade, Clinical Centre Serbia, Belgrade, Serbia.
Prithwish BanerjeeFaculty of Health and Life Sciences, Coventry University, Coventry, UK.
Petar M SeferovicFaculty of Medicine, University of Belgrade, Clinical Centre Serbia, Belgrade, Serbia.
Guy A MacGowanCardiovascular Research Division, Translational and Biosciences Research Institutes, Newcastle University, Newcastle upon Tyne, UK.
Djordje G JakovljevicCardiovascular Research Division, Translational and Biosciences Research Institutes, Newcastle University, Newcastle upon Tyne, UK.ORCID 0000-0003-2686-6542

Funding

European Union's Horizon 2020 Research and Innovation Programme 777204Research Councils UK Centre for Ageing and Vitality L016354
6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2. The clinical presentation of this virus mainly manifests in the respiratory system but may also lead to severe complications in the cardiovascular system. The global burden of COVID-19 has led to an unprecedented need to gain further insight into patient outcomes, management, and clinical practice. This review aims to provide an overview of the current literature on heart failure (HF) hospitalizations, management, and care pathways for supporting patients during and beyond this pandemic. A literature review of five areas of interest was conducted and included: (i) HF hospitalization; (ii) recognizing the needs and supporting HF patients during COVID-19; (iii) supporting rehabilitation services; (iv) transitioning to a telehealth framework; and (v) the need for evidence. Patients with new-onset or existing HF are particularly vulnerable, but a significant reduction in HF hospital admissions has been reported. During these periods of uncertainty, the current care pathways for acute and elective cardiac patients have had to change with the relocation of HF services to protect the vulnerable and reduce transmission of COVID-19. Optimizing community HF services has the potential to reduce the pressures on secondary care during the recovery from this pandemic. Telemedicine and virtual health care are emerging technologies and overcome the risk of in-person exposure. Successful remote delivery of cardiac rehabilitation services has been reported during the pandemic. Delivery of a robust telehealth framework for HF patients will improve communication between clinician and patient. The reduction in HF admissions is a concern for the future and may result in unintended mortality. New-onset and current HF patients must understand their diagnosis and future prognosis and seek help and support using the appropriate platform when needed. Realigning HF services and the use of telemedicine and virtual health care has great potential but needs to be carefully understood to ensure engagement and approval in this population to overcome barriers and challenges.

Indexed as

HospitalizationCOVID-19Critical PathwaysHeart FailureHumansTelemedicineTreatment OutcomeCOVID-19Heart failureHospitalizationsPrimary careTelemedicine

Identifiers

PMID33232587
PMCPMC7753441

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.